10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001035267-23-000196`
Period End Date	20230930
Filing Date	20231020
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	isrg-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 100 Cash Flow Statement 70

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.60B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.58B	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.54B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.87B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$962.70M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$942.10M	USD	Point-in-time
Inventory	`InventoryNet`	$1.15B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$893.20M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$317.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	350.00M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$299.80M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	352.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.25B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.90B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	350.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	352.00M	shares	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$2.37B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$3.08B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$2.62B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.04B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$701.40M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$664.60M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$710.10M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$638.40M	USD	Point-in-time
Goodwill	`Goodwill`	$348.50M	USD	Point-in-time
Goodwill	`Goodwill`	$348.10M	USD	Point-in-time
Total assets	`Assets`	$14.71B	USD	Point-in-time
Total assets	`Assets`	$12.97B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$147.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$196.20M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$374.80M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$401.60M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$397.30M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$394.80M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$710.60M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$476.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.42B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.68B	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$412.80M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$439.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.09B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.86B	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of September 30, 2023, and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of September 30, 2023, and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 600.0 shares authorized, $0.001 par value, 352.0 shares and 350.0 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Common stock, 600.0 shares authorized, $0.001 par value, 352.0 shares and 350.0 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$8.39B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$7.70B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.21B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.50B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-187.60M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-144.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-79.80M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-56.50M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-24.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-162.50M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$12.54B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$11.04B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$70.70M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$84.50M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.95B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.62B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.08B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.96B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.57B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$14.71B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$12.97B	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.74B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.20B	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.56B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.57B	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$505.30M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$1.48B	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$1.74B	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$576.50M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.17B	USD	1 Quarter
Gross profit	`GrossProfit`	$3.09B	USD	3 Qtrs
Gross profit	`GrossProfit`	$3.45B	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.05B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$436.10M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.40B	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.25B	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$452.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$634.90M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$738.70M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$249.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$217.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.88B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$653.20M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.14B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$701.40M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$1.32B	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$465.80M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$1.20B	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$398.90M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$3.90M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$126.40M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$56.20M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$7.50M	USD	3 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$402.80M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.21B	USD	3 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.44B	USD	3 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$522.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$78.10M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$204.40M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$236.40M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$102.20M	USD	1 Quarter
Net income	`ProfitLoss`	$419.80M	USD	1 Quarter
Net income	`ProfitLoss`	$1.01B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.21B	USD	3 Qtrs
Net income	`ProfitLoss`	$324.70M	USD	1 Quarter
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$14.80M	USD	3 Qtrs
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$10.30M	USD	3 Qtrs
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$700.00K	USD	1 Quarter
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.10M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$415.70M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$1.19B	USD	3 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$324.00M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$997.40M	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.91	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.18	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.79	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.40	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.34	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.74	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.16	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.90	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	351.00M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	351.70M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	355.30M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	357.20M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	360.50M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	358.20M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	363.70M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	357.10M	shares	3 Qtrs
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$4.30M	USD	1 Quarter
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$7.70M	USD	3 Qtrs
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$2.30M	USD	1 Quarter
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$12.80M	USD	3 Qtrs
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-37.30M	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-161.40M	USD	3 Qtrs
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$25.60M	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$76.30M	USD	3 Qtrs
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$15.90M	USD	3 Qtrs
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.00M	USD	3 Qtrs
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.80M	USD	1 Quarter
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.00M	USD	1 Quarter
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	3 Qtrs
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-200.00K	USD	3 Qtrs
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-100.00K	USD	1 Quarter
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-165.50M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.90M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$105.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$23.10M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.31B	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$442.90M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$279.80M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$842.20M	USD	3 Qtrs
Less: comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$3.90M	USD	1 Quarter
Less: comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$8.20M	USD	3 Qtrs
Less: comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-800.00K	USD	1 Quarter
Less: comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$13.80M	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$834.00M	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$439.00M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$1.30B	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$280.60M	USD	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$419.80M	USD	1 Quarter
Net income	`ProfitLoss`	$1.01B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.21B	USD	3 Qtrs
Net income	`ProfitLoss`	$324.70M	USD	1 Quarter
Depreciation and loss on disposal of property, plant, and equipment	`DepreciationandGainLossonDispositionofPropertyPlantEquipment`	$283.50M	USD	3 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`DepreciationandGainLossonDispositionofPropertyPlantEquipment`	$239.40M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$5.10M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$7.90M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$20.20M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$15.10M	USD	3 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	$3.80M	USD	3 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-14.70M	USD	3 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-43.40M	USD	3 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$61.00M	USD	3 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$102.00M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$442.40M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$385.60M	USD	3 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$20.70M	USD	3 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$22.60M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$67.20M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$19.70M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$419.10M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$528.20M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$96.80M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-37.50M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$27.70M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$26.30M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-41.90M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-26.80M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-21.20M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-1.00M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$172.10M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$61.60M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.59B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.05B	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$820.20M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.39B	USD	3 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$47.70M	USD	3 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$59.60M	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$2.09B	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$2.54B	USD	3 Qtrs
Purchase of property, plant, and equipment	`PaymentsToAcquireProductiveAssets`	$628.70M	USD	3 Qtrs
Purchase of property, plant, and equipment	`PaymentsToAcquireProductiveAssets`	$393.20M	USD	3 Qtrs
Acquisition of businesses, net of cash, and intellectual property and other investing activities	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$13.10M	USD	3 Qtrs
Acquisition of businesses, net of cash, and intellectual property and other investing activities	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.10M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$796.00M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$684.10M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$188.60M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$252.20M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.30M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$155.40M	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$1.61B	USD	3 Qtrs
Payment of deferred purchase consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$3.50M	USD	3 Qtrs
Payment of deferred purchase consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.90M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-256.10M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.61B	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.70M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$248.00M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.02B	USD	3 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.62B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.55B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.60B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.62B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.55B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.60B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.